Physician profile
Robert P Martyn
NPI 1265422760
$10,227.47
in general payments reported to CMS, 2019-2025
46 companies · $784 in 2025
The $784 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $675 · 2020: $1,077 · 2021: $1,375 · 2022: $2,017 · 2023: $1,428 · 2024: $2,872 · 2025: $784.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,856 · Travel and Lodging: $227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,856.24 |
| Travel and Lodging | $227.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,347.64 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $890.77 | 2020-2024 | Xarelto |
| Astrazeneca Pharmaceuticals Lp | $850.48 | 2020-2024 | Wainua, Farxiga |
| Amgen INC. | $759.62 | 2019-2025 | Repatha, Repatha |
| Penumbra, INC. | $672.06 | 2023-2024 | Indigo System |
| Medtronic, INC. | $601.98 | 2021-2025 | Ffrangio, Onyx Frontier, Symplicity G3 |
| E.R. Squibb & Sons, L.L.C. | $563.53 | 2019-2023 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $497.19 | 2020-2025 | |
| Abbott Laboratories | $450.48 | 2020-2025 | Ultreon, Thoratec Heartmate 3 Lvas Implant Kit |
| Boston Scientific Corporation | $433.56 | 2020-2025 | Watchman Flx, General - Erectile Dysfunction |
| Merck Sharp & Dohme LLC | $352.92 | 2021-2025 | Verquvo, Steglatro |
| Atricure, INC. | $332.73 | 2024 | |
| Lantheus Medical Imaging, INC. | $276.78 | 2019-2024 | Definity |
| Pfizer INC. | $225.41 | 2021-2024 | |
| Amarin Pharma, INC. | $192.28 | 2020 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $183.52 | 2020-2025 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $174.45 | 2019-2024 | |
| Heartflow, INC. | $173.46 | 2024-2025 | |
| Abiomed | $118.60 | 2019 | |
| Cardiovascular Systems INC. | $107.38 | 2020-2022 | |
| Nevro Corp. | $99.54 | 2023 | Senza |
| Actelion Pharmaceuticals US, INC. | $89.09 | 2022-2023 | Opsumit, Uptravi |
| Shockwave Medical, INC | $86.95 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Kiniksa Pharmaceuticals International, Plc | $82.45 | 2024 | Arcalyst |
| Baxter Healthcare | $80.38 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor |
| Sanofi-Aventis U.S. LLC | $78.26 | 2020-2024 | |
| Medtronic Vascular, INC. | $63.79 | 2020 | |
| Lundbeck LLC | $48.26 | 2024 | Rexulti, Vyepti |
| Novo Nordisk INC | $43.79 | 2023-2024 | Wegovy, Ozempic |
| Kiniksa Pharmaceuticals, Ltd. | $41.79 | 2023 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $38.20 | 2023 | Inpefa |
| Cvrx, INC. | $28.42 | 2023 | Barostim Neo System |
| Alnylam Pharmaceuticals INC. | $26.54 | 2020 | |
| Scpharmaceuticals INC. | $21.53 | 2024 | |
| Xeris Pharmaceuticals, INC. | $20.48 | 2025 | Gvoke Hypopen |
| Angiodynamics, INC. | $20.47 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $19.22 | 2023 | Rexulti |
| Zoll Circulation INC | $19.06 | 2022 | |
| Philips North America LLC | $18.17 | 2022 | |
| Arbor Pharmaceuticals, INC. | $17.52 | 2020 | |
| Vital Connect, INC | $17.09 | 2023 | Vitalpatch Rtm |
| Celonova Biosciences, INC. | $16.08 | 2020 | |
| Teleflex LLC | $13.85 | 2023 | Turnpike |
| Alexion Pharmaceuticals, INC. | $13.66 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.54 | 2019 | |
| Vivaquant INC, Dba Rhythm Express | $4.50 | 2025 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Martyn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.